Clinical Trials
🇪🇺 EMA Page 3EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 25–36 of 139 articles
Favipiravir Shipment to Europe Signals Hantavirus Preparedness Amidst Cruise Ship Outbreak
Quoin Pharmaceuticals Aims for First Peeling Skin Syndrome Trial with FDA IND Submission
Oxurion NV Expands GLP-1 and Peptide Research Services Amidst Market Growth
ENYO Pharma Appoints Jeff George as Chairman to Bolster Growth and Phase 3 Readiness for Vonafexor
Eli Lilly's 340B Policy Shift: Impact on Hospital Networks and Pharma Strategy
Karyopharm's Selinexor Plus Ruxolitinib SENTRY Trial Data to be Presented at EHA 2026
OS Therapies Publishes Four Articles on OST-HER2 and Osteosarcoma, Signaling Clinical Progress
EMA celebrates diversity and inclusion in science and healthcare
Arrowhead Pharmaceuticals to Participate in Key June 2026 Industry Events
Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026
UCB's Bimzelx vs. AbbVie's Skyrizi: Psoriatic Arthritis Competitive Landscape
Eisai's Leqembi Sales Forecast: Projecting Blockbuster Status in Alzheimer's